Clinical Trial Update: A Clinical Study to Evaluate CAD-1883 in Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 clinical study of CAD-1883 in essential tremor has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• CAD-1883

Snippet

Sponsor: Cadent Therapeutics | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2021-07-09